Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,147Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Aucta Pharmaceuticals

02 2Towa Pharmaceutical

03 1Acme Lifetech

04 1Aeron Remedies

05 2Alter Laboratories Sa

06 2Alventa Pharma

07 4Amneal Pharmaceuticals

08 4Aurobindo Pharma Limited

09 2Caristar Laboratories

10 2Cinfa

11 2Delius Pharmaceuticals

12 2Dycine Pharma

13 2Efarmes Sau

14 5Faes Farma

15 1Halewood Laboratories Pvt. Ltd

16 1Hanlim Pharmaceuticals Inc

17 2Kern Pharma S.L.

18 3LAB.GUIDOTTI SpA

19 2LABORATORIOS NORMON SA

20 3Menarini

21 1Myungmoon Pharm. Co., LTD.

22 5PTC Therapeutics

23 2STADA Arzneimittel

24 2Sandoz B2B

25 6Sun Pharmaceutical Industries Limited

26 2Swasthya Healthcare

27 3TEOFARMA Srl

28 1Tarbis Farma Sl

29 1Themis Medicare

30 1Tris Pharma Inc

31 1Unicor Pharmatech

32 5Upsher-Smith Laboratories

33 1Vaishali Pharma Ltd

34 1Vega Biotech Pvt. Ltd.

35 2Vir Sa Chemical And Pharmaceutical Industry

36 2Xgx Pharma Aps

37 5ZRS LABS

38 1Zota Healthcare Ltd

39 5Zydus Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

Regulatory Info : RX

Registration Country : USA

DEFLAZACORT

Brand Name : PYQUVI

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2025-06-30

Application Number : 219417

Regulatory Info : RX

Registration Country : USA

Aucta Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

Regulatory Info : Authorized

Registration Country : Spain

Deflazacort

Brand Name : Deflazacort Pensa

Dosage Form : Tablet

Dosage Strength : 30MG

Packaging :

Approval Date : 2011-04-13

Application Number : 73882

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

Regulatory Info : Suspensed

Registration Country : Spain

Deflazacort

Brand Name : Deflazacort Pensa

Dosage Form : Tablet

Dosage Strength : 6MG

Packaging :

Approval Date : 2011-04-13

Application Number : 73883

Regulatory Info : Suspensed

Registration Country : Spain

Towa Pharmaceutical

04

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date :

Application Number : 217173

Regulatory Info :

Registration Country : USA

blank

05

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date :

Application Number : 217173

Regulatory Info :

Registration Country : USA

blank

06

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number : 217173

Regulatory Info :

Registration Country : USA

blank

07

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

08

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

09

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

10

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

11

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

12

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

13

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

14

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

15

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2017-02-09

Application Number : 208685

Regulatory Info : RX

Registration Country : USA

blank

16

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

17

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

18

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

19

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

20

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2025-08-11

Application Number : 216992

Regulatory Info : RX

Registration Country : USA

blank